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Abstract
FGF10 plays an important role in the morphogenesis of several tissues by control of mesenchymal-to-epithelial signaling. In the
pancreas, mesenchymal FGF10 is required to maintain the Pdx1-expressing epithelial progenitor cell population, and in the absence of
FGF10 signaling, these cells fail to proliferate. Ectopic expression of FGF10 in the pancreatic epithelium caused increased proliferation of
pancreatic progenitor cells and abrogation of pancreatic cell differentiation of all cell types. A hyperplastic pancreas consisting of
undifferentiated cells expressing Pdx1, Nkx6.1, and cell adhesion markers normally characterizing early pancreatic progenitor cells resulted.
Differentiation was attenuated even as proliferation of the pancreatic cells slowed during late gestation, suggesting that the trophic effect
of FGF10 was independent of its effects upon cell differentiation. The FGF10-positive pancreatic cells expressed Notch1 and Notch2, the
Notch-ligand genes Jagged1 and Jagged2, as well as the Notch target gene Hes1. This activation of Notch is distinct from the previously
recognized mechanism of lateral inhibition. These data suggest that FGF10 signaling serves to integrate cell growth and terminal
differentiation at the level of Notch activation, revealing a novel second role of this key signaling system during pancreatic development.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
One of the less understood areas of pancreatic develop-
ment is how morphogenesis and cytodifferentiation are con-
nected, and what genetic networks are in effect to control
these processes. Geometrically, the pancreatic structure is
attained by branching morphogenesis of two independent
pancreatic buds, dorsally and ventrally localized (Edlund,
2002). This process is regulated by the interplay of the
pancreatic mesenchyme and an expanding endodermally
derived epithelium. Mechanistically, branching morphogen-
esis is presently best understood in vertebrate lung devel-
opment. Here, spatially controlled signaling among
endodermally secreted morphogens, including sonic hedge-
hog (Bellusci et al., 1997a) and BMP4 (Bone Morphoge-
netic Protein 4) (Weaver et al., 1999; Bellusci et al., 1996)
as well as FGF10 produced by the mesenchyme (Bellusci et
al., 1997b), is pivotal in determining position of new
branches, epithelial outgrowth, and tip arrest. These pro-
cesses are generally mediated by adjustments to the prolif-
erative capacity and chemotaxis of the epithelial cells
(Hogan and Kolodziej, 2002).
Although fundamental differences in tubulogenesis exist
between pancreas and lung (Hogan and Kolodziej, 2002), a
common observation is that as long as branching morpho-
genesis ensues, differentiation is suppressed, allowing for
the expansion of the progenitor cells. Therefore, the genetic
program for the branching morphogenesis might also play a
role connecting it to the programs controlling cytodifferen-
tiation. Early embryological studies have noted a connec-
tion between morphogenesis and cytodifferentiation in the
pancreas. Wessels and Cohen (1967) investigated how pan-
creatic cell differentiation in the rat was affected by alter-
ations in the mesenchymal/epithelial ratio and found that
cytodifferentiation was accelerated if pancreatic mesen-
chyme was depleted. Later studies revealed that removal of
pancreatic mesenchyme would allow for an increased ratio
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Fig. 1. Expression of ectopic FGF10FLAG. (A) Schematic picture of the TG pPDX1-FGF10FLAG construct. (B) Costaining of Pdx1 and FLAG of the WT
pancreas (E14.5) (C). Same, E14.5 TG pancreas, homogenous FGF10-FLAG staining is observed in the Pdx1 cells. (D,E) Anti-FLAG staining of WT (E)
and TG (F) E18.5 pancreas epithelium express FGF10-FLAG. Only TG cells are stained. (F) Closer inspection of the FGF10- FLAG staining pattern of the E14.5
TG embryo reveals that a significant portion of the FLAG-immunoreactivity is localized to the plasma membrane of the epithelial cells. (G) FLAG-
immunoreactivity (red) is also observed within the E14.5 stomach epithelium expressing Pdx1 (green). (H, I) In situ hybridization of FGF10 mRNA in WT
(H) and TG pancreas (I). Heterogeneous expression of FGF10FLAG is observed only within TG epithelium.
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Fig. 2. Expression of pancreatic markers. (A, B) Triple staining of Nkx6.1, insulin, and somatostatin of WT (A) and TG (B) E14.5 pancreas. Insulin cell number
is strongly reduced, but few somatostatin cells (arrows) are present only in TG pancreas. Two types of Nkx6.1 cells are observed: the mature -cell type, which
is Insulin/Nkx6.1 double-positive (white nuclear appearance, abundant in WT), and the remaining precursor cells expressing Nkx6.1 only (abundant in TG). (C).
Triple staining of the exocrine marker amylase (green), with insulin (blue) and glucagon (red) in the WT. Exocrine cells differentiate in the periphery. (D) Same,
TG littermate. No amylase- positive cells are observed. Insulin (blue arrows) and glucagon (red arrows) cells are few. (E) Double-staining of -catenin (red), with
ngn3 (green). Large numbers of ngn3-positive cells are observed. (F) Same, TG littermate. Ngn3 cells are scarce. (G) Ductal differentiation in the WT E14.5
pancreas is signified by DBA-lectin binding (outlined). (H) TG littermate shows no binding of DBA lectin. Asterisks (*) denote erythrocytes.
of endocrine versus exocrine cell differentiation (Gittes et
al., 1996; Miralles et al., 1998) Also, under such conditions,
the branching process of the epithelium was completely
inhibited.
Little is known of why experimental abolition of the
mesenchymal–epithelial interaction has such a profound
impact upon differentiation and morphology. Most of the
genes known to control pancreatic cell fates do not seem to
be rigidly patterned prior to development of the individual
cell types. This is true for Pdx1 (Jonsson et al., 1994; Øster
et al., 1998; Guz et al., 1995), Nkx2.2 (Sussel et al., 1998),
and Nkx6.1 (Øster et al., 1998). Also, many seem to play a
role farther down in the differentiation pathway instead of
initial lineage establishment [Pax6 (Sander et al., 1997;
St-Onge et al., 1997), Isl1 (Ahlgren et al., 1997), NeuroD
(Naya et al., 1997)]. Therefore, except for the proendocrine
gene Atoh5 (encoding ngn3), which is expressed only in the
central domains of the pancreas as -cells form (Gradwohl
et al., 2000; Gu et al., 2002; Jensen et al., 2000a), informa-
tion remains lacking as to how patterning within the pan-
creatic organ is conferred prior to differentiation of pancre-
atic cellular subtypes.
Recently, FGF10 was found to be critically involved in
pancreagenesis. FGF10 is normally expressed by the distal-
most pancreatic mesenchyme at early stages, and Fgf10-null
mouse embryos display a hypoplastic pancreas, attributed to
loss of the proliferative phase of the pancreas epithelial
progenitor cells (Bhushan et al., 2001). The progenitor cells
normally express the homeodomain factor Pdx1, which it-
self is required for pancreatic progenitor cell expansion.
Thus, the effects of FGF10 were explained by a loss of Pdx1
expression. The detrimental effect of the mutant, however,
significantly hindered interpretation of the role of FGF10 in
pancreatic development at later stages.
For this reason, we generated a transient transgenic (TG)
mouse model (pPDX1-FGF10FLAG mice) with the objective
of revealing later effects of FGF10 in pancreatic develop-
ment. Furthermore, we aimed to test the hypothesis that
mesenchymal FGF10 signaling acts not only to maintain
epithelial growth through induction of epithelial cell prolif-
eration (Bhushan et al., 2001), but in addition may serve to
maintain Notch-signaling active in pancreatic epithelial
cells, thereby simultaneously suppressing cell fate determi-
nation. Our data suggest that FGF-signaling has such a dual
effect upon pancreatic development, providing a molecular
framework that may help in understanding the link between
pancreatic cytodifferentiation and morphogenesis.
Materials and methods
Cloning of pPDX1-FGF10FLAG
The open reading frame for mouse FGF10 was amplified
from lung tissue and fused C-terminally in-frame with the
FLAG sequence, incorporated in the downstream primer.
The flank of the upstream primer codon was changed to
match the consensus Kozak sequence (CCACC). Primers
included EcoRI sites for cloning. The fragment was inserted
into the pPDX1-EcoRI-vector (Jacob Hald), which includes
the Pdx1 regulatory region and a -globin splice cassette.
The pPDX1- FGF10FLAG fragment for oocyte injection was
released by BssHII digest (Fig. 1A).
Transgenic mice derivation and embryo isolation
Viable oocytes (FVB  FVB, 100–150/day) were in-
jected (DNA conc. 20 ng/l) and transferred to pseudopreg-
nant recipients. A total of eight independent injection
rounds were produced for this study. Genotyping was per-
formed on either yolk sac or paw tissue using gene-specific
primers. Date of transfer was set as gestational day E0.5.
Embryo/tissue isolation was performed in ice-cold PBS
under a stereomicroscope (Olympus SZX12) allowing vi-
sual inspection of the entire gut. BrdU (20 mg/kg) was
injected 2 h prior to isolation of embryos.
Histology
Histochemistry was performed on frozen sections (7
m). At day of staining, slides were dried at 37°C for 30
min, transferred to PBS, and microwaved at boiling for 2 
5 min in 10 mM citric acid buffer, pH 6.0. Slides were
allowed to cool (30) prior to 3 washes in 1 PBS.
Blocking of unspecific reactivity was performed at RT/1 h
using a proprietary TSA-block, supplied by Perkin-Elmer.
A mix of diluted 1°-antibodies was added following block-
ing with no washing, and left O/N. The next morning,
excess 1°-antibodies were removed by 3 washes by 1
PBS. A matching mix of fluorophore-conjugated secondary
antibodies was added (1:100, e.g., Cy2-Donkey-anti-rabbit,
Texas Red-donkey-anti-mouse, AMCA-donkey-anti-
guinea pig) for 1 h. Secondary antibodies were obtained
from Jackson ImmunoResearch. Excess secondary antibody
was washed off by 3 washes in 1 PBS. In certain cases,
TSA-stimulated amplification was performed to increase
signal strength. TSA-amplification of a select color channel
(green) was performed by using FITC-TSA reagent (Perkin
Elmer, cat. #: NEN-701). Primary antibodies were here
detected by using “Histostain kit” reagents (Zymed). HRP
activity was revealed by using the HRP-catalyzed tyramide
reaction of FITC-TSA. Controls without primary antibodies
were included. Antibody identity, source, and dilution are as
follows: rabbit -IDX1 (PDX1), Joel Habener, Boston, MA,
USA, 1:2000 (DIF); rabbit -HES-1, Nadean Brown, Ann
Arbor, MI, USA, 1:5000 (TSA); rabbit -Nkx6.1, Ole D.
Madsen, Gentofte, Denmark, 1:500 (DIF); mouse -Soma-
tostatin, DAKO, 1:500 (DIF); rabbit -Amylase, A8273,
1:1000 (DIF) Sigma, St. Louis, MO, USA; mouse -BrdU,
Bu20A, 1:100 (DIF) DAKO A/S, Denmark; G. pig -insu-
lin, GP31, 1:1000 (DIF) Novo-Nordisk, Denmark; mouse
-glucagon, K79BB10, 1:100 (DIF) Sigma, St. Louis, MO,
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USA; rabbit -chromogranin A, 18-0094, 1:100 (DIF)
Zymed, CA, USA; -PP, 18-0043 rabbit 1:500 (DIF)
DAKO, Denmark; rabbit -Ngn3, 1:500 (TSA) Dr. H. Ed-
lund, Umeå, Sweden; rabbit -IAPP, G017-11, 1:100 (DIF),
Phoenix Pharmaceuticals, AZ, USA; rabbit -pHistoneH3,
06-570, 1:500 (DIF), Upstate, Charlottesville, VA, USA;
rabbit -PCNA, FL-261, 1:50 (DIF) Santa Cruz Biotech.,
CA, USA; rabbit --catenin Ab-1, 1:100 (DIF) Neomar-
kers/labvision, CA, USA; rat -E-cadherin, ECCD2, 1:200
(DIF), Zymed, CA, USA; mouse -FLAG-Cy2, M2, 1:100
(DIF), Sigma, St. Louis, MO, USA; Rhodamine-DBA lectin
RL-1032, 25 g/ml Vector Labs, CA, USA.
Three E12.5, 6 E14.5, and 3 E18.5 TG embryos were
histologically characterized. These groups were qualita-
tively similar (based on Pdx1, Nkx6.1, and FLAG staining
patterns). N  3 WT littermate embryos were included per
time point in pairwise comparisons.
ISH was performed as follows. First, 1 g of linearized
template DNA was in vitro transcribed and labeled with
digoxygenin-UTP (DIG). The RNA was subsequently pre-
cipitated adding 1 l glycogen (20 g/ml; Roche), 7 l 7.5
M ammonium acetate, 75 l cold 100% EtOH, resuspended
in H2O, reprecipitated using ammonium acetate/cold EtOH,
and resuspended in DEPC water. Slides were dried for 30
at 37°C. Hydrophobic barriers around individual sections
were generated by using a PAP-pen (Zymed). Sections were
refixed by using 4% PFA for 10 followed by 3 5 washes
in 1 PBS. Proteinase K digestion was not performed.
Sections were acetylated followed by washing in 3  5 in
1 PBS. Then, 500 l preheated (55°C) hybridization so-
lution was added to each slide for prehybridization [5
SSC, 50% formamide, 50 g/ml yeast tRNA (Sigma), 1%
SDS, 50 g/ml heparin (Sigma)]. Hybridization mix was
prepared by adding 1 l probe to 100 l hybridization
solution. Slides were coverslipped during hybridization O/N
in a humidified chamber at 70°C. The next day, coverslips
were removed by immersion in preheated 5 SSC followed
by posthybridization washes: 0.2 SSC, 3 h, 70°C; 0.2
SSC, 5, RT, and 1 MAB, 5, RT. Blocking was per-
formed for 1 h by submersion into blocking solution (2%
blocking reagent (Roche), 10% heat-inactivated sheep se-
rum, 0.1% Tween 20, 1 MAB). Slides were incubated
with anti-DIG-AP or anti-FLU-AP (1:5000) conjugated sec-
ondary antibodies in blocking solution O/N at 4°C. The next
day, slides were washed 3 /20 at RT in 1  MAB/0.1%
Tween 20. Finally, slides were transferred to NTMT (0.1 M
Tris, 400 mM NaCl, 50 mM MgCl2, 0.1% Tween 20).
Signal was visualized by using the AP-substrate BM-purple
(Roche). Probe information is as follows (Gene name, vec-
tor, source): Fgf10, pCR4, Own; Notch1 and Notch2, pBK-
CMV, Dr. Jacob Hald, Denmark; Jagged1, pCMV-
SPORT6, IMAGE: 3500602, ResGen; Jagged2, pSK, Dr.
Gerry Weinmaster, UCLA; Hes1, pBS-SKII, Dr. R.
Kageyama, U. Kyoto, Japan; Ptf1a, pCR-bluntll, Dr. Lori
Sussel, UCHSC, USA.
Morphometry
All morphometric analyses were done on digitized im-
ages by using ImagePro software v4.5 (Media Cybernetics).
Defined areas of interest were quantified by using area
integration. Cell numbers were manually counted for each
field-of-vision (FOV). At least 10 independent FOVs were
quantified per time point on different slides (n  3). Total
cell number analyzed was (WT): 466 BrdU/1907 -Cate-
nin, (TG): 2518 BrdU/6928 -Catenin. Cell density
was calculated as cells/mm2  s.d. A similar method was
used for quantifying phosphohistone H3 (pHH3) frequency/
area.
Results
Generation of pPDX1-FGF10FLAG transgenic mice
We generated a construct containing a full-length, C-
terminally FLAG-tagged FGF10 coding region under con-
trol of the Pdx1 promoter (Fig. 1A). This vector contains 4.5
kb of the upstream regulatory elements of the mouse pdx1
promoter, which has been shown to faithfully mimic endog-
enous Pdx1 expression (Stoffers et al., 1999; Apelqvist et
al., 1997; Li and Edlund, 2001). Thus, this promoter allows
for abundant expression in the developing pancreas and
lower levels of expression in the posterior stomach and
duodenal epithelium. The pPDX1-FGF10FLAG construct
was injected into fertilized oocytes, and TG embryos were
isolated at various ages through gestation; no line establish-
ment was attempted. Gross anatomical evaluation combined
with histological analysis showed that all carriers but one
(94%, 15/16), at all ages studied, displayed a pronounced
endodermal phenotype affecting lung, stomach, pancreas,
and intestinal development. We describe here the effects on
pancreatic development.
We obtained a total of n  16 independent carriers at
three different time points: E12.5 (n  3), E14.5 (n  9),
E18.5 (n  4). At E14.5, visual inspection of microdis-
sected foregut–midgut regions revealed an alteration on
overall morphology of the TG carriers compared with wild
type (WT) littermates. Pancreatic development was dis-
turbed. The regular triangular shape of the dorsal pancreatic
rudiment did not develop; instead, an enlarged bulk of tissue
was positioned on the side of the stomach. Farther down on
the presumptive duodenum, a large mass of ventral pancre-
atic tissue was observed. At E18.5, the morphological char-
acteristics described above of the E14.5 guts were exacer-
bated.
We first determined expression of the FGF10FLAG trans-
gene. At both E12.5 (not shown) and E14.5, homogeneous
expression of FGF10FLAG protein was found in Pdx1-ex-
pressing cells throughout a hyperplastic pancreatic epithe-
lium (Fig. 1C). No FLAG-staining was observed in WT
Pdx1 cells (Fig. 1B). Expression of FGF10 FLAG protein
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persisted in E18.5 pancreas epithelium (Fig. 1E). Surpris-
ingly, at all time points, the strongest staining was observed
in the plasma membrane rather than in the cytoplasm (Fig.
1F). FGF10FLAG protein was also observed in Pdx1-ex-
pressing stomach epithelial cells, albeit at lower levels (Fig.
1G). The staining for the FLAG- tagged protein was always
homogenous within the Pdx1-expressing cells, an unex-
pected finding as the embryos correspond to independent
integration events and some of which may be mosaic. As
FGF10 is a secreted protein, it seems possible that by
visualizing the FLAG-tagged protein we might detect
FGF10FLAG postsecretion, likely binding to cognate recep-
tors and possibly internalized. To clearly define the cellular
subset expressing the exogenous FGF10 gene, we per-
Fig. 3. Continued suppression of cytodifferentiation by FGF10 in the late-stage pancreas. (A) Triple staining of Nkx6.1 (green), insulin (blue), and
somatostatin (red), WT pancreas. At E18.5, only few remaining precursor cells are remaining (single- positive Nkx6.1 cells). These extend to the stem of
the exocrine Nkx6.1 acini. Most ductal cells do not express Nkx6.1. All insulin-positive cells express Nkx6.1. Somatostatin-positive cells are scarce. (B)
Same, TG littermate. Few scattered insulin/Nkx6.1 coexpressing cells are observed. Very few somatostatin cells are detectable. The majority of cells in the
expanded pancreatic epithelium express Nkx6.1. (C) Exocrine differentiation is pronounced in the WT pancreas, signified by formation of acinar structures
(amylase, green). Glucagon cells cluster in a similar manner as the insulin-producing cells. (D) Same, TG littermate. A limited number of cells have taken
an exocrine fate (amylase, green). The glucagon cell number is strongly reduced. (E, F) Ptf1a in situ hybridization. Ptf1a is expressed both in the WT and
TG pancreatic cells. Low-level expression of Ptf1a remains in certain ductal cells in the WT (outlined).
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Fig. 4. Cell proliferation. (A) Morphometric analysis of BrdU incorporation. Data are based on -catenin/BrdU double staining of E14.5 pancreas.
BrdU/-catenin cells were counted relative to total -catenin cells. (B) Morphometric analysis of phosphorylated Histone H3 frequency. Data based on
colabeling with E-cadherin and pHH3. Error bars, s.d.; *, P  0.05; ***, P  0.001. (C, D) Double staining of BrdU (red) and - catenin (green), E14.5.
(E, F) Triple staining of BrdU (red), insulin (blue), and - catenin (green), E18.5. Fully differentiated exocrine cells, as well as -catenin ductal-type cells
are BrdU in WT (E). In the transgenic pancreas (F), -catenin cells within the extended ductal network are labeling with a low frequency compared with
E14.5 (D).
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formed in situ hybridization for FGF10. High levels of
exogenous FGF10 mRNA were detected in the developing
E14.5 pancreas epithelium of TG carriers (Fig. 1I), and none
in WT littermates (Fig. 1H). No mesenchymal expression of
FGF10 was noted. Lack of mesenchymal FGF10 expression
was expected as the endogenous FGF10 expression is nor-
mally restricted between E9.5 and E12.5 (Bhushan et al.,
2001). TG Pancreatic FGF10 mRNA expression was highly
heterogeneous. Thus, local dispersion of the FGF10 protein
may explain why all pancreatic cells display a membranous
staining pattern of the protein. Due to the secreted nature of
FGF10, we speculated that the unexpected phenotype in the
lung might be due to diffusion of FGF10 produced by the
pancreas and stomach, thereby conditioning the lumen of
the gut. Western blot analysis of transgenic amniotic fluid
failed to reveal the presence of FGF10FLAG protein (data not
shown). However, RT-PCR revealed the presence of low
amounts of exogenous FGF10 mRNA in transgenic lung
(data not shown).
Pancreatic cell differentiation in pPDX1-FGF10FLAG mice
In order to characterize FGF10-mediated effects on pan-
creatic cell differentiation, we first wished to clarify which
cells of the midgut region were truly in a pancreatic state.
As Pdx1 is not restricted to the pancreas, we took advantage
of the pancreas-restricted endodermal marker Nkx6.1. In
E14.5 WT embryos, Nkx6.1 is restricted to few centrally
located remaining progenitor cells and mature -cells (Fig.
2A). In TG littermates, almost all cells of the pancreatic-
type epithelium expressed Nkx6.1 (Fig. 2B). Costaining for
Pdx1 and Nkx6.1 revealed that most cells coexpressed these
markers (data not shown). By analyzing the expression of
terminal markers of differentiated pancreatic cells, we found
that insulin expression was strongly reduced (Fig. 2B and
D), while in the normal pancreas, large numbers of insulin-
expressing cells have developed (Fig. 2A and C) at an
approximate 1:1 ratio with glucagon-expressing cells (Fig.
2C). Glucagon-expressing cells were found in TG pancreas,
but in reduced numbers (Fig. 2D). A few Somatostatin-
expressing cells were observed in the E14.5 TG pancreas
(Fig. 2B, and data not shown), whereas these cells were not
present in the WT littermates at this age (Fig. 2A). This
could signify an altered fate allocation for cells in the
/-cell lineage. The exocrine-specific marker amylase was
absent in TG pancreas at E14.5 (Fig. 2D), but readily de-
tectable in the WT littermates (Fig. 2C).
FGF10-mediated suppression of endocrine differentiation
occurs upstream of the proendocrine gene Atoh5/ngn3
The almost complete absence of endocrine cell formation
could be explained by a repressive effect of FGF10 signal-
ing at various levels of endocrinogenesis. Multiple cell
intrinsic regulators play roles at different levels of endocrine
cell formation. For instance, both Isl1 and Pax6 are required
for proper endocrine differentiation but act after an endo-
crine cell type has made a fate commitment and has become
postmitotic. Extremely few Pax6-positive cells were ob-
served in E14.5 TG pancreas compared with WT, and the
majority of these expressed either insulin or glucagon (data
not shown). The reduced number of Pax6 cells suggested
that the repressive effect of FGF10 might have targeted the
initiation of endocrine development. To clarify this, we
analyzed expression of the proendocrine factor Ngn3 (Grad-
wohl et al., 2000). Ngn3 was expressed in the TG pancreas
at a greatly reduced cell number compared with WT (Fig.
2E and F). Therefore, FGF10 seem to have inhibited the
propensity of any given pancreatic progenitor cell to initiate
an endocrine program by blocking Ngn3 activation.
FGF10 arrests pancreatic epithelial cells in an
undifferentiated state
The absence of terminal differentiation and the homoge-
neous Nkx6.1 and Pdx1 expression at E14.5 suggested that
the FGF10FLAG-expressing cells were trapped in a pheno-
typic state resembling that of the normal expanding pancre-
atic epithelium during its major growth phase between the
primary and secondary transitions. We next asked if this
state was maintained throughout embryonic development by
analyzing expression of pancreatic markers at E18.5. At this
point, most WT pancreatic precursors have undergone a fate
allocation toward either an endocrine (insulin or gluca-
gon; Fig. 3A and C) or exocrine (amylase; Fig. 3C) fate,
with very few Pdx1/Nkx6.1/hormone progenitor cells
remaining (Fig. 3A). In the E18.5 TG pancreas, most cells
expressed Pdx1, where some of these also expressed
Nkx6.1, albeit at strongly reduced levels compared with
E14.5 (data not shown). In E18.5 WT pancreas, Nkx6.1 and
Pdx1 colocalize in -cells (data not shown), and Pdx1 is
only expressed at very low levels in mature exocrine cells.
Total endocrine cell number in the E18.5 TG pancreas was
considerably reduced as evaluated by the panendocrine
marker ChromograninA (data not shown) and scattered in-
sulin, glucagon, somatostatin, and PP cells were
found adjacent to the TG epithelium (Fig. 3B and D, and not
shown). The overall pancreatic morphology was highly cys-
tic, consisting almost entirely of tubular networks. At this
time point a relatively small portion of cells in the periph-
eral regions had adopted an exocrine fate (Amylase; Fig.
3D). We conclude that cellular differentiation is not irre-
versibly blocked in TG embryos. To evaluate a possible
mechanism to account for the reduction of exocrine cell
differentiation, we analyzed expression of the Ptf1a gene,
which is normally expressed both in pancreatic progenitor
cells, and later is involved in the exocrine fate choice
(Kawaguchi et al., 2002). Ptf1a was expressed in both WT
and TG E14.5 pancreas epithelium (not shown), as well as
in the cystic epithelium of the E18.5 TG pancreas and
mature WT exocrine cells (Fig. 3E and F). Thus, suppres-
sion of exocrine differentiation occurs downstream of Ptf1a.
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Early pancreatic progenitor cells have been shown to
express particular cell-adhesion molecules. -Catenin is a
protein with pleiotropic functions, one of which is associ-
ated with maintenance of the epithelial morphology through
its interaction with cell adhesion molecules of the cadherin
family. Both -catenin and E-cadherin are normally ex-
pressed strongly in pancreatic epithelial progenitors (Se-
lander and Edlund, 2002; and data not shown). E-cadherin
and -catenin were expressed homogeneously in E14.5 TG
epithelial cells, contrasting the heterogenous pattern of the
WT pancreas. Uniform staining was also observed in the
epithelial structures at E18.5 (data not shown). Again, such
a pattern was not observed in WT littermates, where only
ductal cells (Pdx1) and few Pdx1/hormone cells display
a similar qualitative staining (data not shown). Thus, a
possibility was that the FGF10- expressing epithelial cells
had taken a ductal fate. Therefore, we performed staining
for Dolichos Biflorus Agglutinin (DBA lectin); (Kobayashi
et al., 2002) which we find exclusively staining duct cells.
No cells labeled with DBA lectin in the TG epithelium
[analyzed at E14.5 (Fig. 2G and H) and E18.5 (not shown)],
arguing that the TG pancreatic cells had not undergone
ductal differentiation.
Triple immunofluorescence of BrdU (5-Bromo-deoxy-
Uridine) S-phase incorporation together with pancreatic
markers (-catenin and insulin) at both E14.5 (Fig. 4C and
D) and E18.5 (Fig. 4E and F) allowed us to discriminate
between the mitotic activities of pancreatic progenitor cells
and mesenchymal cells (Fig. 4A). Insulin cells did not
incorporate BrdU in E14.5 or E18.5 TG pancreas, whereas
WT insulin cells had a low mitotic activity at E18.5 (data
not shown) and none at E14.5, in agreement with previous
data (Jensen et al., 2000a). In contrast, the -catenin-ex-
pressing epithelial cells were strongly proliferating in both
WT and TG pancreas. Still, a 1.49-fold increase in the
BrdU-labeling index was observed between TG vs. WT
pancreas (Fig. 4A). To complement the BrdU measure-
ments, we performed double staining of phosphorylated
histone H3 (pHH3) in combination with E-cadherin (Fig.
4B). A similar fold increase of the proliferative index (1.47-
fold) between TG and WT E14.5 pancreas epithelium was
observed. At E18.5, the proliferative capacity had strongly
declined in both the TG as well as the WT pancreas (Fig.
4B). However, a relative increase in the proliferation of the
TG pancreas epithelium at E18.5 was still observed (Fig.
4B). No significant difference in mesenchymal proliferation
was observed at E14.5 or E18.5 (Fig. 4B).
FGF10-expressing pancreatic progenitor cells remain
active in Notch signaling
As precursor cell arrest combined with inhibition of
differentiation is the expected outcome if Notch signaling is
sustained in the developing pancreas (Apelqvist et al.,
1999), we analyzed expression of components of this sig-
naling system. Notch1 and Notch2 are normally expressed
by the developing mouse pancreas. Normal expression of
Notch1 is restricted to the developing pancreatic buds at
E10 (Apelqvist et al., 1999; Lammert et al., 2000) and
continue in the pancreatic epithelial progenitors prior to
endo- and exocrine differentiation, as well as in the remain-
ing progenitors following the secondary transition
(Apelqvist et al., 1999; Lammert et al., 2000; Jensen et al.,
2000a). Notch2 is normally expressed both by pancreatic
epithelium and mesenchyme early (Jensen et al., 2000b) but
becomes restricted to remaining ductal progenitor cells at
E15.5 (Lammert et al., 2000). In E18.5 FGF10FLAG TG
embryos, Notch1 and Notch2 expression persisted in the
arrested epithelium (Fig. 5D and F), while we noted that
expression of Notch1 and Notch2 was absent in the few
exocrine cells that differentiated, similar to the exocrine
cells of the WT (Fig. 5C and E). Expression of Notch1 and
Notch2 suggests competence for Notch signaling but does
not reveal whether Notch signaling is active. Therefore, we
investigated the expression status of Hes1 as this gene is a
known downstream target for Notch1 and 2 (Jarriault et al.,
1998; Beatus et al., 2001) and generally accepted to signify
active Notch signaling (Jouve et al., 2000; Kuroda et al.,
1999; Solecki et al., 2001; Jarriault et al., 1998). We found
that Hes1 was expressed in most cells of the E18.5 TG
epithelium, contrasting its restriction to ductal-type cells in
the WT (Fig. 5A and B).
To evaluate the mechanism for the continued Notch
activation, we addressed the expression of Notch-ligand
genes. Delta1 (encoded by Dll1), which is normally ex-
pressed in the earliest differentiating endocrine cells (Lam-
mert et al., 2000), was only expressed in very few cells of
both WT and TG pancreas at E12.5 (data not shown) and
only a low level expression of Dll1 in both the WT and TG
pancreas at E14.5 (not shown). We did not detect expression
of Dll1 in WT or TG E18.5 pancreas (data not shown). In
contrast, we observed a strong and uniform expression of
Jagged2 (Fig. 6D) in the E18.5 TG pancreas. Similarly;
Jagged1 was expressed broadly in the TG epithelium at
lower levels (Fig. 6B). These domains overlapped those
regions that still expressed FGF10FLAG mRNA (Fig. 6F).
Jagged1 and Jagged2 were abundantly expressed in the
forming vasculature (Fig. 6A and B) within the pancreas
interstitial area of both TG and WT. The epithelial expres-
sion of Jagged1 and Jagged2 could imply that these ligands
play a role during the normal epithelial expansion prior to
the secondary transition. Epithelial-restricted pancreatic ex-
pression of Jagged1 prior to differentiation has previously
been reported (Mitsiadis et al., 1997). We find Jagged2
expressed in both WT and TG pancreatic epithelium at
E12.5 (data not shown), overlapping cells also expressing
Notch2, Notch1, and Hes1 (data not shown). Thus, Jagged1,
Jagged2, Notch1, Notch2, and Hes1 are coexpressed within
the normal pancreatic progenitor cells prior to the secondary
transition. This pattern is maintained in the TG epithelium.
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Discussion
In the current study, FGF10 was overexpressed in the
pancreatic epithelial progenitor cells using the Pdx1 pro-
moter. FGF10 is thus targeted to a cell type not normally
expressing the ligand, but to one that is responsive to the
factor (Bhushan et al., 2001; Miralles et al., 1999). It is
conceivable that epithelial-expressed FGF10 sensed by the
mesenchyme subsequently signaling back to the epithelium
could explain some of the observed effects. However, this
appears less likely than the probability that exogenous
FGF10FLAG protein exerts auto- or paracrine effects. We
base this argument on the fact that the predominant cognate
receptor for FGF10, the III-b-splice form of the FGFR2, is
Fig. 5. Sustained activation of the Notch signaling system by FGF10. (A) In situ hybridization of hes1, E18.5 WT. Hes1 is expressed almost exclusively in
ductal structures of the normal pancreas. (B) TG littermate, Hes1 is expressed throughout the epithelium, with varying intensity. (C) Notch1 is only expressed
in pancreatic duct cells, and absent in exocrine pancreatic cells. (D) In contrast, Notch1 is expressed throughout the epithelial cells of the TG pancreas. (E)
Notch2 is not expressed in the normal pancreas at E18.5. (F) Notch2 remains expressed at high levels in the precursor epithelium of the TG pancreas. The
cells that undergo exocrine differentiation cease to express Notch2 (asterisks), similar to WT exocrine cells. Mesenchymal cells do not express Notch2 at this
time point.
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expressed in the pancreas epithelium and not in the adjacent
mesenchyme (Elghazi et al., 2002; Miralles et al., 1999).
Furthermore, FGF10 protein was only detected within the
epithelial cells of the pancreas. Additionally, mesenchymal
cell proliferation is not altered in the TG embryos. In normal
lung and pancreas, FGF10 is secreted by the distal-most
mesenchyme, causing outgrowth of those epithelial cells in
proximity to the signaling source. The production of FGF10
in lung creates a morphogen gradient that influences spatial
gene expression (Bellusci et al., 1997b; Weaver et al., 2000;
Park et al., 1998) and we assume the existence of a similar
morphogen gradient in the pancreas. In the current model,
the autocrine FGF10 production would effectively disrupt
such a gradient. Given the high level of expression
Fig. 6. Expression of Jagged-type Notch-ligand genes in pPDX1-FGF10 pancreas. (A) In situ hybridization of Jagged1, E18.5 WT. Jagged1 is expressed
exclusively in endothelial cells (*). (B). TG littermate, Jagged1 is expressed in endothelial cells (*). In addition, most cells of the pancreatic epithelium
express Jagged1. (C) Jagged2 is expressed in endothelial cells (*), and absent in exocrine pancreatic cells. Some staining is observed in endocrine regions
(#). (D) Jagged2 is expressed in TG pancreas throughout the pancreatic epithelial cells. (E, F) In situ hybridization for FGF10 mRNA reveals continued
expression of the transgene in the E18.5 pancreas (F), whereas the control WT pancreas is negative (E). Expression in the TG pancreas (F) varies greatly
between individual epithelial cells. The general domains of transgene expression overlap those expressing the various Notch genes.
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achieved, it is likely that the pancreatic epithelium would be
exposed to FGF10 concentrations that may correspond to
that of a proximal position to the mesenchyme. Cells in such
a proximal position in the lung activate bmp4 expression in
response to FGF10 (Bellusci et al., 1996; Weaver et al.,
2000). However, as we cannot detect Bmp4 mRNA in WT
nor TG pancreas (data not shown), this genetic network
does not seem to operate in the developing pancreas.
Active suppression by FGF10 of pancreatic cell
differentiation
Based on the results of the FGF10-null mice, we antic-
ipated that ectopic FGF10 secretion would lead to an in-
crease in pancreatic epithelial cell proliferation. The 1.5-
fold upregulation in mitotic index of -catenin/E-cadherin-
positive epithelial progenitors at E14.5 is consistent with
this and would account for the hyperplastic pancreas ob-
served. Somewhat unexpectedly we find that cytodifferen-
tiation of the principal cell types in the pancreas (endocrine,
exocrine and ductal) is strongly repressed. Bhushan and
coworkers found that glucagon cells did not form prema-
turely, or in excess, in FGF10-deficient embryos thereby
suggesting that FGF10 did not play a role in repressing
differentiation. Also, Miralles et al. (1999) proposed that
FGF-signaling is instructive for the exocrine pancreatic fate,
as explanted pancreatic epithelia were found to contain
increasing numbers of exocrine cells when cultured in the
presence of FGF10 (or FGF7, FGF1). Our data do not
support the notion that FGF10 is instructive for exocrine
development, as this fate choice is completely repressed at
E14.5. The discrepancy between these studies might be
explained by the absence of the precursor cell expansion
phase in isolated epithelial explant cultures without FGF
signaling, as this would lead to reduced numbers of exocrine
cells developing in total. Thus, the addition of exogenous
FGF would rescue the mesenchymal trophic effect, allow-
ing for normal pancreatic epithelial development and later
differentiation of exocrine cells. In such a case, the role of
FGF10 should be viewed as a permissive, rather than in-
structive, signal for exocrine cell development. Our data
also contrast the results by Hart et al. (2000) where expres-
sion of a presumed dominant negative FGFR2b under con-
trol of the Pdx1 promoter does not lead to developmental
defects. Considering the degree of the phenotype of Pdx1-
FGF10FLAG transgenic embryos observed here, it is surpris-
ing that the pPDX1-DN-FGFR2b mice do not display a
detectable embryonic phenotype manifestation. One possi-
bility explaining this difference is that the FGFR2b receptor
may not mediate all signaling from FGF10, and that such an
alternative pathway is not blocked by the DN-FGFR2b
receptor. In turn, this can also explain the relatively weak
pancreatic hypoplasia phenotype manifested by FGFR2b
mutant mice (Pulkkinen et al., 2003). Predicting the com-
ponents of such an alternative signaling pathway is not
straightforward, as multiple FGFRs (FGFR1b/c, FGFR2
b/c, FGFR3b/c, FGFR4, and FGFR5) are all expressed
during pancreatic development (Dichmann et al., 2003). Of
note, Dichmann et al. (2003) recently described the effects
of ectopic expression of FGF4 in the pancreas, suggesting
some similarity between the pPDX1-FGF4 and pPDX1-
FGF10FLAG mice (this study), such as cystic epithelial for-
mation and the attenuation of endocrine development in
both models. Yet, important differences are clear as exo-
crine development was not blocked in the pPDX1-FGF4
mice, and perhaps more important, the pancreatic mesen-
chymal mitotic activity was highly elevated; whereas this
parameter is unchanged in pPDX1-FGF10 mice. FGF4 is
known to signal through the FGFR1,2,3-c but not the
FGFR1,2,3-b splice forms nor FGFR4 (Bellosta et al.,
2001). Due to the different signaling pathways of FGF10
and FGF4, it is not straightforward to determine the reason
for the similarities between these models. In our opinion,
secondary effects caused by the increase in pancreatic mes-
enchymal tissue mass in the pPDX1-FGF4 model could
well be responsible for the observed effects on endocrine
development and cystic network formation. It would be of
interest to determine whether FGF10 is expressed in the
pPDX1-FGF4 mesenchymal tissue.
We find that FGF10-expressing pancreatic progenitor
cells become arrested in the undifferentiated precursor state,
characterized by the expression of Pdx1, Nkx6.1, cell ad-
hesion molecules, Notch, Hes1, and Jagged genes. Thus,
ectopic FGF10 appears to have blocked the normal wave of
differentiation events occurring at the secondary transition.
In the endocrine differentiation pathway, the block occurs
upstream of the proendocrine factor Ngn3. The loss of Ngn3
expression in TG embryos signifies that the earliest known
cue for endocrine development is not activated; however,
this does not unambiguously demonstrate that the conse-
quences upon cytodifferentiation are due to an active re-
pression mechanism, rather than a default block of matura-
tion as the cells remain in the cycling state due to an
otherwise independent trophic effect of FGF10. Cell cycle
exit is an integral part of the endocrine differentiation path-
way, as endocrine cells become postmitotic upon differen-
tiation (Ahlgren et al., 1997; Jensen et al., 2000a). Impor-
tantly, the mitotic arrest in endocrine formation occurs
downstream of Ngn3 gene activation (Jensen et al., 2000a),
showing that this event is a consequence, rather than the
basis for initiating the endocrine program. Consequently,
we deduct that FGF10 actively suppresses initial Ngn3 pro-
moter activation. Our finding that most pancreatic cells are
still blocked in differentiation at E18.5 while showing re-
duced mitotic activity supports this conclusion.
By what mechanism then is FGF10 actively suppressing
pancreatic cell differentiation? Notch-signaling normally
acts to repress Atoh5/Ngn3 expression during normal endo-
crine pancreatic development. One aspect of this inhibition
pivots around a lateral specification mechanism, whereby
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cells of proendocrine character signal laterally between
neighbors, restricting a primary fate allocation to one and
simultaneously repressing the process in the other (Fig. 7B).
Such a mechanism is supported by investigations of the
effects upon mutation of either the Notch downstream gene
Hes1, the Su(h)-type transducer RBP-J, or the Notch li-
gand Dll1 (Apelqvist et al., 1999; Jensen et al., 2000b).
However, the almost complete conversion of pancreatic
progenitors at E9.0–E10 and the lack of endocrine cell
clustering in the Hes1/ intestine, combined with the
observation that Hes1 is widely expressed in epithelial cells
of the normal presecondary transition pancreas even in cells
not neighboring a laterally signaling cell (Jensen et al.,
2000b), suggest that Notch signaling is not required for
every aspect of Hes1 expression, or alternatively, that a
second mechanism beyond lateral inhibition activating
Notch/Hes1 ubiquitously in the pancreatic progenitor cells
exists. The second possibility has received experimental
support, as mice mutant for Hnf6 express Notch and Hes1 at
nonreduced levels despite the almost complete absence of
Atoh5/Ngn3 expression and loss of endocrine cells (Jacque-
min et al., 2000).
“Suppressive maintenance” by Notch: a possible role for
Notch/Hes1 prior to lateral inhibition
Our findings of the effects of FGF10 signaling further
supports such an additional role of Notch-activation, as
Hes1 is clearly activated by a process different from lateral
inhibition. This role is linked to precursor cell maintenance,
and to discriminate it from the lateral inhibition mechanism,
we will refer to this as “suppressive maintenance” defined
by Notch-mediated Hes gene activation throughout the pre-
cursor cell population with the outcome that cell differen-
tiation cues are suppressed and the progenitor state is main-
tained. The difference between such a suppressive
maintenance role of Notch and that of Notch in lateral
inhibition is depicted in Fig. 7. A distinguishing feature
between these mechanisms is the ubiquitous expression of
the ligand and receptor in suppressive maintenance, in con-
trast to the typical speckled expression of a lateral inhibitory
ligand, such as that reported for Dll1 (Lammert et al., 2000).
Both Jagged1 and Jagged2 exhibit such a uniform pattern in
the normal pancreatic epithelial cells prior to the secondary
transition, and are thus overlapping with Notch1 and Notch2
(this study and Jensen et al., 2000a; Apelqvist et al., 1999;
Lammert et al., 2000; Mitsiadis et al., 1997). This pattern is
maintained in the presence of ectopic FGF10. The control of
Notch activation during suppressive maintenance would be
expected to be distinct from that of lateral inhibition. Due to
the established effect of the pancreatic mesenchyme in as-
sisting epithelial growth prior to differentiation, such dis-
tinction may be conferred through mesenchymal signaling
(Fig. 7A). Supporting this are the results of isolated epithe-
lial culture, where differentiation occurs toward an endo-
crine fate, rather than exocrine. An additional, although
generally overlooked, conclusion from such experiments is
that the isolated epithelial cells do not rest in the precursor
state, but in fact undergo an accelerated differentiation.
Such an outcome is similar to the effects on pancreatic
development in vivo of an absence of Hes1 (Jensen et al.,
2000b), where the endocrine, and not the exocrine, fate is
accelerated, and occurs in excess.
FGF signaling and Notch-mediated suppressive
maintenance: a conserved molecular cassette?
Is FGF-stimulated progenitor cell maintenance via the
Notch system a unique feature of the developing pancreas?
Although a link between FGF signaling and Notch activa-
tion as a conserved gene regulatory cassette is not com-
monly recognized several observations suggest such an as-
sociation in several developmental contexts, such as the
developing limb (Crosnier et al., 2000; Vargesson et al.,
1998) where FGF8 and 10 signaling regulates expression of
Jagged1 and Jagged2 during distal outgrowth (Shawber et
al., 1996; Valsecchi et al., 1997). Likewise, in the develop-
ing tooth (Harada et al., 2002), FGF10 is capable of main-
taining the dental epithelial precursor pool via stimulation
of Hes1 (Mustonen et al., 2002). A specific model of FGF/
Notch interaction combined with a temporal definition of
two modes of Notch signaling is that of tracheal develop-
ment in Drosophila (Ikeya and Hayashi, 1999), where the
fly gene branchless (FGF-type) leads to FGF-receptor acti-
vation (breathless) and downstream MAPK signaling caus-
ing upregulation of delta in the inductive process of tracheal
cell invagination. Later, notch plays a second role (lateral
inhibition) in the selection of fusion versus tracheal fates. A
related bimodal system may be also involved in vertebrate
somite differentiation. In Zebrafish (Sawada et al., 2001)
and chicken (Dubrulle et al., 2001), FGF8 secreted by the
caudal presomitic mesoderm (PSM) has been proposed as a
wavefront generator in the clock-and-wavefront model of
somitogenesis. Dubrulle and colleagues observed that an
increase in FGF8 protein levels did not affect the periodicity
of the clock mechanism, but resulted in an increase in the
Notch-target gene c-hairy-2 in the PSM (Dubrulle et al.,
2001). Reciprocally, the lowering of FGF-signaling resulted
in reduced c-hairy2 expression. Therefore, the role of FGF
signaling in the PSM could be to set a noncyclical Notch
activity threshold, which thus can be viewed as the actual
wavefront (Holley and Takeda, 2002) [i.e., suppressive
maintenance restricting condensation] on top of which a
cyclical oscillating Notch output (Evrard et al., 1998; Zhang
and Gridley, 1998) serves to operate, and against which
differentiation cues push. If such a system indeed exists one
may expect a ligand for Notch to be under control of FGF
signaling, expressed in a decreasing gradient rostrally in the
PSM. Both Dll1 and Dll3 display such a distribution within
the PSM (Kusumi et al., 1998).
This study shows that increased FGF10 signaling results
in the maintenance of Notch signaling in pancreatic devel-
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opment. Future investigations designed to test for a causal
link between these two signaling mechanisms could help
clarify to what extent FGF and Notch signaling may inter-
act. Of particular importance is to identify the cell intrinsic
regulator(s) that exert the transcriptional effects of FGF10
in the pancreas. Such component(s) could well belong to a
family of MAPK-regulated transcription factors. Presently,
no good candidates exist among those genes that are known
to play roles in the development of the pancreas. Our data
suggest that Jagged1 and Jagged2 may link FGF10 and
Notch signaling. Currently, our data do not allow us to
prove that the Jagged-genes are immediate targets of the
FGF signaling cascade, and further studies are needed to test
such a causal link. Of key importance will be to test if
Jagged1 and Jagged2 promoter activation is a direct or
indirect response to FGF10 signaling. Also, it remains a
possibility that other signaling pathways may influence the
activity state of Notch, some of which may include other
ligand/receptor pairs that regulate a MAPK-cascade. Not-
withstanding, our data provide evidence that FGF10 is ca-
pable of maintaining the pancreatic progenitor cell state, and
we believe this knowledge could aid attempts to control
pancreatic precursor pool expansion, followed by controlled
differentiation in a future -cell replacement therapy for
patients with diabetes.
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